Elixir Medical Corporation

Print Article


Elixir Medical Corporation to Showcase the Next Generation Bioresorbable Novolimus Eluting Coronary Scaffold Systems -- DESolve CX and AMITY® at EuroPCR 2016

Elixir TNT Symposium with Key Thought Leaders Scheduled for May 17

Sunnyvale, CAMay 11, 2016—Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it will showcase demonstration of the next-generation 120µm thin-strut bioresorbable scaffold system, DESolve CX at EuroPCR in Paris. EuroPCR is the annual meeting of the European Association for Percutaneous Cardiovascular Interventions.

The Elixir TNT Symposium scheduled for Tuesday, May 17th at Theatre Bleu, will also feature the world’s first fully bioresorbable scaffold system specifically designed for AMI (Acute Myocardial Infarction) patients, the AMITY® Novolimus Eluting Coronary Scaffold System, in addition to follow-up results from the DESolve® NX study at 3 years, and pipeline clinical programs.

Following are some of the highlights of Elixir Medical’s programs and activities at the EuroPCR conference (in chronological order) at the Palais Des Congres de Paris in Central European Summer Time (CEST):

Tuesday, May 17

12:54 – 12:57, Room 241

OCT evaluation of the vascular responses of the polylactide-based, novolimus-eluting BRS from implantation to three years: insights from the DESolve NX trial

13:45 – 13:53, Room 343

A new novolimus-eluting BRS for large coronary arteries: An OCT study of acute mechanical performance

15:30 – 16:00, Elixir Booth #F7

Meet the Expert: BRS in the Daily Practice: Tips and Tricks

17:15 – 18:45, Theatre Bleu

Elixir Medical TNT Symposium
Evolving BRS Techniques to the AMI Patient: Elixir DESolve to AMITY



Wednesday, May 18

13:35 – 14:35, Room 343

Planned and ongoing clinical trials: Update on DESolve Programme

15:30 – 16:00, Elixir Booth #F7

Meet the Expert: BRS in the Daily Practice: Tips and Tricks

Thursday, May 19

13:52 – 14:02, Room 343

Next-generation BRS clinical trials: DESolve, Mirage FIM, Phantom, MeRes

17:09 – 18:00, Room 351

BRS, evolving technologies and applications (DESolve vs. DESolve 100)

17:22 – 17:30, Room 351

DESolve NX 3yr

Friday, May 20

09:00 – 10:30, Room 25B

Contemporary DES: Focus on bioresorbable polymers (Part 2) EXCELLA BD

Elixir Medical will have a booth at EuroPCR:  Booth # F7, Second Floor. The booth will be open Tuesday, May 17 through Friday, May 20.

About Elixir Medical
Elixir Medical Corporation, a privately held company headquartered in Sunnyvale, California, develops products that combine state-of-the-art medical devices with advanced pharmaceuticals to provide innovative treatment solutions to patients worldwide. The company's next-generation drug-eluting stent systems and bioresorbable coronary scaffold are designed to optimize localized drug delivery to provide safe and effective treatments for cardiovascular patients. For more information, visit www.elixirmedical.com




Donna Collins
Elixir Medical
Ph: (408) 636-2060